ANI Pharmaceuticals マネジメント
マネジメント 基準チェック /34
ANI Pharmaceuticalsの CEO はNikhil Lalwaniで、 Sep2020年に任命され、 の在任期間は 4.17年です。 の年間総報酬は$ 8.08Mで、 9.5%給与と90.5%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の1.92%を直接所有しており、その価値は$ 21.43M 。経営陣と取締役会の平均在任期間はそれぞれ3年と4.2年です。
主要情報
Nikhil Lalwani
最高経営責任者
US$8.1m
報酬総額
CEO給与比率 | 9.5% |
CEO在任期間 | 4.2yrs |
CEOの所有権 | 1.9% |
経営陣の平均在職期間 | 3yrs |
取締役会の平均在任期間 | 4.2yrs |
経営陣の近況
Recent updates
ANI Pharmaceuticals Is Acting Like It Is Being Acquired
Nov 02ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market
Oct 11There's No Escaping ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Muted Revenues
Sep 10ANI Pharmaceuticals' (NASDAQ:ANIP) Earnings Are Weaker Than They Seem
Aug 14Is ANI Pharmaceuticals (NASDAQ:ANIP) Using Too Much Debt?
Aug 08ANI Pharmaceuticals: Tezruly Just Approved, 2 More NDAs Under Review And Alimera Science Acquisition Could Triple Revenue By 2028
Aug 02Subdued Growth No Barrier To ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Price
Jun 10ANI Pharmaceuticals Is Undervalued, As Royalty Potential Is Overlooked
Jun 10These 4 Measures Indicate That ANI Pharmaceuticals (NASDAQ:ANIP) Is Using Debt Reasonably Well
Feb 17Additional Considerations Required While Assessing ANI Pharmaceuticals' (NASDAQ:ANIP) Strong Earnings
Nov 15Does ANI Pharmaceuticals (NASDAQ:ANIP) Have A Healthy Balance Sheet?
Sep 22Does ANI Pharmaceuticals (NASDAQ:ANIP) Have A Healthy Balance Sheet?
Feb 22We Think ANI Pharmaceuticals (NASDAQ:ANIP) Has A Fair Chunk Of Debt
Oct 28ANI Pharma launches generic Prochlorperazine maleate tablets
Aug 29ANI Pharmaceuticals' generic dexamethasone tablets get FDA approval
Aug 16ANI Pharmaceuticals Q2 2022 Earnings Preview
Aug 05CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Jun 30 2024 | n/a | n/a | US$23m |
Mar 31 2024 | n/a | n/a | US$31m |
Dec 31 2023 | US$8m | US$764k | US$15m |
Sep 30 2023 | n/a | n/a | US$10m |
Jun 30 2023 | n/a | n/a | -US$8m |
Mar 31 2023 | n/a | n/a | -US$28m |
Dec 31 2022 | US$5m | US$737k | -US$50m |
Sep 30 2022 | n/a | n/a | -US$69m |
Jun 30 2022 | n/a | n/a | -US$65m |
Mar 31 2022 | n/a | n/a | -US$63m |
Dec 31 2021 | US$7m | US$715k | -US$43m |
Sep 30 2021 | n/a | n/a | -US$22m |
Jun 30 2021 | n/a | n/a | -US$17m |
Mar 31 2021 | n/a | n/a | -US$15m |
Dec 31 2020 | US$4m | US$199k | -US$23m |
報酬と市場: Nikhilの 総報酬 ($USD 8.08M ) は、 US市場 ($USD 3.21M ) の同規模の企業の平均を上回っています。
報酬と収益: Nikhilの報酬は、過去 1 年間の会社の業績と一致しています。
CEO(最高経営責任者
Nikhil Lalwani (46 yo)
4.2yrs
在職期間
US$8,078,353
報酬
Mr. Nikhil Lalwani served as a Director of Association for Accessible Medicines. He served as the Chief Executive Officer of InvaGen Pharmaceuticals, Inc. since October 24, 2016. Mr. Lalwani is a seasoned...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
President | 4.2yrs | US$8.08m | 1.92% $ 21.4m | |
Senior VP of Finance & CFO | 8.5yrs | US$2.58m | 0.83% $ 9.3m | |
Senior Vice President of Corporate Development & Strategy | 3yrs | US$1.90m | 1.24% $ 13.9m | |
Senior Vp & Head of Rare Disease | 3.8yrs | US$1.91m | 0.43% $ 4.8m | |
Senior Vice President of Generics | 3.8yrs | US$1.94m | 0.40% $ 4.4m | |
Head of R&D | 3yrs | データなし | 0.26% $ 2.9m | |
Senior Vice President of Operations | 8.5yrs | US$1.43m | 0.60% $ 6.8m | |
Chief Compliance Officer & Head of Legal of Rare Disease | 2.8yrs | データなし | データなし | |
Senior VP | 2.3yrs | データなし | 0.29% $ 3.2m | |
Senior VP & Chief Human Resources Officer | 2.2yrs | データなし | 0.26% $ 2.9m | |
Chief Medical Officer | 2.8yrs | データなし | データなし | |
Senior VP & Head of Established Brands | 3yrs | データなし | 0.17% $ 2.0m |
3.0yrs
平均在職期間
51.5yo
平均年齢
経験豊富な経営陣: ANIPの経営陣は 経験豊富 であると考えられます ( 3年の平均在職年数)。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
President | 4.2yrs | US$8.08m | 1.92% $ 21.4m | |
Head of R&D | 3yrs | データなし | 0.26% $ 2.9m | |
Independent Chairman | 6.5yrs | US$422.21k | 0.38% $ 4.3m | |
Independent Director | 4.3yrs | US$393.25k | 0.16% $ 1.8m | |
Independent Director | 6.5yrs | US$412.21k | 0.26% $ 3.0m | |
Independent Director | 4.3yrs | US$395.75k | 0.21% $ 2.3m | |
Independent Director | 2.7yrs | US$392.37k | 0.12% $ 1.3m | |
Independent Director | 1.3yrs | US$470.76k | 0.061% $ 687.4k |
4.2yrs
平均在職期間
61.5yo
平均年齢
経験豊富なボード: ANIPの 取締役会 は 経験豊富 であると考えられます ( 4.2年の平均在任期間)。